IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 2,445.00
+50.00 (2.09%)
Nov 2, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 34.27 billion as of October 30, 2026. It is the 35,277th most valuable company in the world and the 2,072nd biggest in South Korea. Its market cap has decreased by 77.69% in one year.
Market Cap
34.27B
Enterprise Value
16.63B
Revenue
5.60B
Global Rank
Country Rank
#2,072 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 34.27B, a decrease of -93.20%. That is a compound annual growth rate of -64.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 34.27B | -75.28% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 133.68B |
| MedPacto | 104.54B |
| Genexine | 98.24B |
| Vaxcell-Bio Therapeutics | 86.63B |
| iNtRON Biotechnology | 86.19B |
| Amicogen | 64.54B |
| ENCell | 51.56B |
| GeneOne Life Science | 48.42B |